Evidence map›Paper›PMID 40470973›Full record

ArticleMicrobiology spectrum2025

Amanda Azevedo Bittencourt, Vinicius Lima Faustino, Paula de Mendonça Batista, Lays Paulino Leonel, Marina Della Negra de Paula, Thales José Polis

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Microbiology spectrum, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Amanda Azevedo BittencourtGlobal Medical & Scientific Affairs (GMSA), MSD Brazil, São Paulo, Brazil.ORCID 0000-0001-5464-2381
Vinicius Lima FaustinoGlobal Medical & Scientific Affairs (GMSA), MSD Brazil, São Paulo, Brazil.ORCID 0000-0001-8306-7646
Paula de Mendonça BatistaGlobal Medical & Scientific Affairs (GMSA), MSD Brazil, São Paulo, Brazil.
Lays Paulino LeonelReal World Evidence, IQVIA Brazil, São Paulo, Brazil.
Marina Della Negra de PaulaGlobal Medical & Scientific Affairs (GMSA), MSD Brazil, São Paulo, Brazil.
Thales José PolisGlobal Medical & Scientific Affairs (GMSA), MSD Brazil, São Paulo, Brazil.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Study for Monitoring Antimicrobial Resistance Trends (SMART) surveillance program tested imipenem/relebactam (IMR) and comparators against a total of 2,258 non-duplicate clinical isolates of

Indexed as

Anti-Bacterial AgentsAzabicyclo CompoundsEnterobacteriaceaeImipenembeta-LactamasesBrazilDrug Resistance, Multiple, BacterialEnterobacteriaceae InfectionsEscherichia coliHospitalsHumansKlebsiella pneumoniaeMicrobial Sensitivity TestsAnti-Bacterial AgentsAzabicyclo Compoundsbeta-LactamasesImipenemrelebactamantibioticsbacterial infectionsEnterobacteralesimipenem/relebactamsurveillance

Identifiers

PMID40470973
PMCPMC12211073

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.